0
0

Cart (0)

Home > Categories > Octreotide

Octreotide

Sort by
Wishlist

Des-D-Trp(4)-Octreotide

  • CAT NUMBER DCTI-D-100
  • CAS NUMBER NA
  • MOLECULAR FORMULA C38H56N8O9S2
  • MOLECULAR WEIGHT 833.03
Wishlist
Wishlist

Des-Lys(5)-Octreotide

  • CAT NUMBER DCTI-D-101
  • CAS NUMBER NA
  • MOLECULAR FORMULA C43H54N8O9S2
  • MOLECULAR WEIGHT 891.07
Wishlist
Wishlist

Des-Threoninol-Octreotide

  • CAT NUMBER DCTI-D-094
  • CAS NUMBER NA
  • MOLECULAR FORMULA C45H57N9O9S2
  • MOLECULAR WEIGHT 932.13
Wishlist
Wishlist

L-Phe(1)-Octreotide

  • CAT NUMBER DCTI-D-098
  • CAS NUMBER NA
  • MOLECULAR FORMULA C49H66N10O10S2
  • MOLECULAR WEIGHT 1019.25
Wishlist
Wishlist

L-Threoninol(Ac)-8-Octreotide

  • CAT NUMBER DCTI-D-095
  • CAS NUMBER NA
  • MOLECULAR FORMULA C51H68N10O11S2
  • MOLECULAR WEIGHT 1061.28
Wishlist
Wishlist

Linear octreotide

  • CAT NUMBER DCTI-D-097
  • CAS NUMBER NA
  • MOLECULAR FORMULA C49H68N10O10S2
  • MOLECULAR WEIGHT 1021.26
Wishlist
Wishlist

Lys(Ac) 5 Octreotide

  • CAT NUMBER DCTI-D-092
  • CAS NUMBER NA
  • MOLECULAR FORMULA C51H68N10O11S2
  • MOLECULAR WEIGHT 1061.28
Wishlist
Wishlist

N-formyl-D-Phe-Octreotide

  • CAT NUMBER DCTI-D-254
  • CAS NUMBER NA
  • MOLECULAR FORMULA C50H66N10O11S2
  • MOLECULAR WEIGHT 1047.26 Da
Wishlist
Wishlist

OCA Thr-O-Glycolic ester (1.19RRT)+ Thr-O-Sec (Gly...

  • CAT NUMBER DCTI-D-233
  • CAS NUMBER NA
  • MOLECULAR FORMULA C51H68N10O12S2
  • MOLECULAR WEIGHT 1077.28 Da
Wishlist
LOAD MORE
You're viewed 18 of 26 products
References
FAQ's

References

  1. Wilflried Bauer, Lampenberg; Janos Pless, Sandoz Ltd, “Novel Polypeptides, Processes For Their Production, Pharmaceutical Compositions Comprising Said Polypeptides And Their Use” US patent, US 4,395,403, July 26, 1983
  2. Edwards, W. Barry; Fields, Cynthia G.; Anderson, Carolyn J.; Pajeau, Tammy S.; Welch, Michael J.; Fields, Gregg B., “Generally Applicable, Convenient Solid-Phase Synthesis and Receptor Affinities of Octreotide Analogs” Journal of Medicinal Chemistry, Volume: 37, Issue: 22, Pages: 3749-57,1994

Frequently Asked Questions

Octreotide impurities are removed through a combination of purification techniques, such as chromatography, crystallization, and filtration.

Octreotide impurities are identified using analytical techniques such as high-performance liquid chromatography (HPLC), and liquid chromatography-mass spectrometry (LC-MS).

The synthesis of Octreotide impurities involves the use of various chemical reactions, such as peptide coupling, esterification, and protection/deprotection steps.

Impurities can have a significant impact on the safety, efficacy, and stability of Octreotide. They can affect the drug's pharmacological properties, increase the risk of adverse reactions, and reduce the shelf life of the drug.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart
jQuery(window).on('load', function() { $('input[name="productname"]').val($('.product_title').html()); });